Low factor XII level in an individual with Sotos Syndrome

Pediatric Blood and Cancer

Volumn 44, Issue 2, 2005, Pages 187-189

  Shen, Joseph J ^a   Kurotaki, N ^a   Patel, A ^a   Lupski, J R ^a,b   Brown, C W ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Contiguous gene deletion syndrome; Factor XII; FISH; Genomic deletion; Sotos syndrome

Indexed keywords

BLEOMYCIN; BLOOD CLOTTING FACTOR 12; CISPLATIN; ETOPOSIDE;

ARTICLE; CANCER RISK; CASE REPORT; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; FACE DYSMORPHIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GENE LOCUS; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; MALE; NEUROLOGIC DISEASE; NEWBORN; NSD1 GENE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEX CORD TUMOR; SOTOS SYNDROME;

ABNORMALITIES, MULTIPLE; CHILD, PRESCHOOL; CRANIOFACIAL ABNORMALITIES; FACTOR XII; FACTOR XII DEFICIENCY; GIGANTISM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NUCLEAR PROTEINS; SYNDROME;

EID: 11144297186     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20177     Document Type: Article

References (13)

1. Opitz J, Weaver DW, Reynolds JF, Jr. The syndromes of Sotos and Weaver: Reports and review. Am J Med Genet 1998;79:294-304.
2. Kurotaki N, Imaizumi K, Harada N, et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 2002;30:365-366.
3. Douglas J, Hanks S, Temple IK, et al. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet 2003;72:132-143.
4. Rio M, Clech L, Amiel J, et al. Spectrum of NSD1 mutations in Sotos and Weaver syndromes. J Med Genet 2003;40:436-440.
5. Kurotaki N, Harada N, Shimokawa O, et al. Fifty microdeletions among 112 cases of Sotos syndrome: Low copy repeats possibly mediate the common deletion. Hum Mutat 2003;22:378-387.
6. Nagai T, Matsumoto N, Kurotaki N, et al. Sotos syndrome and haploinsufficiency of NSD1: Clinical features of intragenic mutations and submicroscopic deletions. J Med Genet 2003;40:285-289.
7. Lammle B, Wuillemin WA, Huber I, et al. Thromboembolism and bleeding tendency in congenital factor XII deficiency-A study on 74 subjects from 14 Swiss families. Thromb Haemost 1991;65: 117-121.
8. Halbmayer W, Mannhalter C, Feichtinger C, et al. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost 1992;68:285-290.
9. Zeerleder S, Schloesser M, Redondo M, et al. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency. Thromb Haemost 1999;82:1240-1246.
10. Helft G, Le Feuvre C, Metzger JP, et al. Factor XII deficiency associated with coronary stent thrombosis. Am J Hematol 2000;64: 322-323.
11. Soria J, Almasy L, Souto JC, et al. A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet 2002;70: 567-574.
12. Nicholls J, Chan LC, Koo YM, et al. Subdural haematoma and factor XII deficiency in a Chinese infant. Injury 1993;24:202-203.
13. Miyake N, Kurotaki N, Sugawara H, et al. Preferential paternal origin of microdeletions caused by prezygotic chromosome or chromatid rearrangements in Sotos syndrome. Am J Hum Genet 2003;72:1331-1337.